hotspot -WSS

hotspot

author：hotspot 2025-09-30 00:36:49 - browse：8

David Liu and Jonathan Wosen on the STAT Summit stage. — David Liu (left) with reporter Jonathan Wosen at the 2022 STAT Summit. STAT

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body, STAT has learned.

The company, known as Nvelop, already raised a $100 million seed round last year, according to PitchBook. It is being run by Jeff Walsh, a former top executive at Bluebird Bio, and it recently recruited Bluebird’s head of research, Melissa Bonner, according to two people with knowledge of the situation. Bluebird had not previously disclosed Bonner’s departure.

Nvelop is the latest entry in a race among top labs and deep-pocketed investors to solve a delivery problem that has stunted efforts to turn CRISPR and other genetic tools into disease-altering medicines. The goal is to develop a cargo system precise enough to deliver CRISPR or other machinery to cells of a researchers’ choosing, particularly tissues that have been hard to reach with previous approaches, like neurons, muscle, and blood stem cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： J&J reports mixed data on next

WSS

Decentralized clinical trials need collaboration to achieve wider use

Naloxone nonprofit donates 200,000 doses after FDA approval

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

In same hospitals, Black patients receive fewer opioids than white patients

focus

hotspot

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

The best solution to the drug shortages problem

DIEP, the 'gold standard' of breast reconstruction, is under threat

Louisiana bill approved classifying abortion pills as controlled substances

Jerome Adams on the need for new antivirals for Covid

Police still searching for prisoner who escaped from NYC hospital

In Memoriam: Notable people who died in 2023

Guardant Health colon cancer test endorsed by FDA advisory panel

Sports medicine is finally prioritizing gender equality

Wegovy trial has doctors encouraged over new possibilities

hotspot

Medical students need to learn the potent medicine of empathy

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Unmasking the 'centricity' illusion in clinical trials

Wegovy trial has doctors encouraged over new possibilities

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

hotspot

entertainment

explore

entertainment